Delivery Order SPE2DB20D1100-SPE2DB25FZ18M
Award Date
11/21/24
Potential Completion Date
11/22/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,419.42 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,886.13 firm fixed-price delivery order contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,429.17 Firm Fixed Price Delivery Order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,094.27 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,379.43 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a period of performance through January 16, 2025. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,039.11 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support the DLA's medical requirements. The contract has an ultimate completion date of July 11, 2024 and was awarded on July 10, 2024. This award is associated with Amerisourcebergen's $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.45 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,555.32 contract is for the delivery of OPZELURA 1.5% Cream, a prescription pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $4,557.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OPZELURA 1.5% cream, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 24, 2024, and is structured as a firm fixed-price agreement. The award is not associated with a set-aside designation, indicating open...
This federal contract award, valued at $1,623.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a 60-gram pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...